Potentially inappropriate medication use in elderly japanese patients

American Journal Geriatric Pharmacotherapy

Volumn 8, Issue 2, 2010, Pages 146-160

  Akazawa, Manabu ^a   Imai, Hirohisa ^b   Igarashi, Ataru ^c   Tsutani, Kiichiro ^c  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Beers criteria; Cost; Drug utilization review; Elderly; Incidence; Potentially inappropriate medication; Utilization

Indexed keywords

DRUG;

AGED; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; DATA BASE; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; JAPAN; MALE; MEDICATION ERROR; POLYPHARMACY; RETROSPECTIVE STUDY; STANDARD; STATISTICAL MODEL; STATISTICS;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES AS TOPIC; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; RETROSPECTIVE STUDIES;

EID: 77954933946     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2010.03.005     Document Type: Article

References (42)

1. Ministry of Health, Labour and Welfare. Annual Health, Labour and Welfare Report 2007-2008. http://www.mhlw.go.jp/english/wp/wp-hw2/. Accessed October 16, 2009.
2. Bates DW, Spell N, Cullen DJ, et al, for the Adverse Drug Events Prevention Study Group. The costs of adverse drug events in hospitalized patients. JAMA. 1997; 277:307-311.
3. Mita Y, Akishita M, Tanaka K, et al. Improvement of inappropriate prescribing and adverse drug withdrawal events after admission to long-term care facilities. Geriatr Gerontol Int. 2004;4:146-150.
4. Simonson W, Feinberg JL. Medication-related problems in the elderly: Defining the issues and identifying solutions. Drugs Aging. 2005;22:559-569.
5. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345-351.
6. Zhang M, Holman CD, Price SD, et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: Retrospective cohort study. BMJ. 2009;338: a2752.
7. Avorn J, Shrank WH. Adverse drug reactions in elderly people: A substantial cause of preventable illness. BMJ. 2008;336:956-957.
8. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825-1832.
9. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157:1531-1536.
10. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts [published correction appears in Arch Intern Med. 2004;164:298]. Arch Intern Med. 2003;163:2716-2724.
11. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother. 2000;34:338-346.
12. Fialov D, Topinkov E, Gambassi G, et al, for the AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348-1358.
13. Niwata S, Yamada Y, Ikegami N. Prevalence of inappropriate medication using Beers criteria in Japanese longterm care facilities. BMC Geriatr. 2006;6:1.
14. Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113-121.
15. Lin HY, Liao CC, Cheng SH, et al. Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases: Experience in a Taiwanese medical setting. Drugs Aging. 2008;25:49-59.
16. Fick DM, Waller JL, Maclean JR, et al. Potentially inappropriate medication use in a Medicare managed care population: Association with higher costs and utilization. J Manag Care Pharm. 2001;7:407-413.
17. Fu AZ, Jiang JZ, Reeves JH, et al. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care. 2007;45:472-476.
18. Page RL II, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother. 2006;4:297-305.
19. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med. 2007;147:755-765.
20. Jano E, Aparasu RR. Healthcare outcomes associated with Beers' criteria: A systematic review. Ann Pharmacother. 2007;41:438-447.
21. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: A national consensus panel. CMAJ. 1997;156: 385-391.
22. Naugler CT, Brymer C, Stolee P, Arcese ZA. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7:103-107.
23. Barry PJ, O'Keefe N, O'Connor KA, O'Mahony D. Inappropriate prescribing in the elderly: A comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther. 2006;31:617-626.
24. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008;37:673-679.
25. Ryan C, O'Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68:936-947.
26. Imai H, Beers MH, Fick DM, et al. Development of Japanese Beers Criteria for inappropriate medication use in elderly patients [in Japanese]. Japan Med Assoc J. 2008;137:84-91.
27. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Version for 2007. http://apps.who.int/classifications/apps/icd/icd10online/. Accessed March 7, 2010.
28. Ministry of Health, Labour and Welfare. Ethical guidelines for epidemiological research [in Japanese]. http://www.niph.go.jp/wadai/ ekigakurinri/rinrishishin-071101.htm#1. Accessed March 7, 2010.
29. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
30. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD- 10 administrative data. Med Care. 2005;43:1130-1139.
31. Medical Care Act (Act No. 205 of 1948) [in Japanese]. http://www.houko.com/00/01/S23/205.HTM#s4. Accessed March 7, 2010.
32. SAS/STAT 9.1 User's Guide: The GLM Procedure (Book Excerpt). Cary, NC: SAS Institute Inc; 2008.
33. Yuan Y, Padol IT, Hunt RH. Peptic ulcer disease today. Nat Clin Pract Gastroenterol Hepatol. 2006;3:80-89.
34. Lazzaroni M, Bianchi Porro G. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects. Dig Liver Dis. 2001; 33(Suppl):S44-S58.
35. Mattila MA, Larni HM. Flunitrazepam: A review of its pharmacological properties and therapeutic use. Drugs. 1980;20:353-374.
36. Wang PS, Bohn RL, Glynn RJ, et al. Hazardous benzodiazepine regimens in the elderly: Effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158:892-898.
37. Mauri MC, Bravin S, Bitetto A, et al. A risk-benefit assessment of sulpiride in the treatment of schizophrenia. Drug Saf. 1996;14:288-298.
38. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med. 2000;342:1773-1777.
39. Chen YC, Hwang SJ, Lai HY, et al. Potentially inappropriate medication for emergency department visits by elderly patients in Taiwan. Pharmacoepidemiol Drug Saf. 2009;18:53-61.
40. Social Insurance Agency. Overview of the Social Insurance Systems. http://www.sia.go.jp/e/index.html. Accessed October 16, 2009.
41. IT Strategic Headquarters. Priority Policy Program 2007. http://www.kantei.go.jp/foreign/policy/it/index-e.html. Accessed October 16, 2009.
42. Japanese Society for Pharmacoepidemiology. Provisional translation of the report of the working group on "Future Postmarketing Surveillance in Japan" (published in 2003). http://www.jspe.jp/mt-static/FileUpload/files/ pms-en.pdf. Accessed March 7, 2010.